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In the present study, 13-residue peptides with sequences corres-
ponding to the native N-terminal segment of pulmonary SP-C
(surfactant protein C) have been synthesized and their interaction
with phospholipid bilayers characterized. The peptides are soluble
in aqueous media but associate spontaneously with bilayers com-
posed of either zwitterionic (phosphatidylcholine) or anionic
(phosphatidylglycerol) phospholipids. The peptides show higher
affinity for anionic than for zwitterionic membranes. Interaction
of the peptides with both zwitterionic and anionic membranes
promotes phospholipid vesicle aggregation, and leakage of the
aqueous content of the vesicles. The lipid–peptide interaction in-
cludes a significant hydrophobic component for both zwitterionic
and anionic membranes, although the interaction with phos-
phatidylglycerol bilayers is also electrostatic in nature. The effects
of the SP-C N-terminal peptides on the membrane structure
are mediated by significant perturbations of the packing order
and mobility of phospholipid acyl chain segments deep in the
bilayer, as detected by differential scanning calorimetry and spin-
label ESR. These results suggest that the N-terminal region of
SP-C, even in the absence of acylation, possesses an intrinsic
propensity to interact with and perturb phospholipid bilayers,
thereby potentially facilitating SP-C promoting bilayer-mono-
layer transitions at the alveolar spaces.
Key words: lipid–protein interaction, membrane perturbation,
monolayer, phospholipid bilayer, protein palmitoylation, pul-
monary surfactant.
INTRODUCTION
Lipopeptide SP-C (surfactant protein C) is expressed specifically
in mammalian lung tissue, forming part of pulmonary surfactant,
a lipid–protein complex that modulates surface tension at
the respiratory air–liquid interface to stabilize bronchoalveolar
structure. Phospholipids, especially DPPC (1,2-dipalmitoylphos-
phatidylcholine), play a major biophysical role in surfactant
because of their ability to form stable interfacial monomolecular
films, which are able to achieve and sustain very low surface ten-
sions. Other components of the surfactant complex, such as the
anionic phospholipid PG (1,2-diacylphosphatidylglycerol) and
specific surfactant-associated proteins, are required for pulmonary
surfactant to undergo complex and dynamic transformations in
the airspaces [1,2]. Hydrophobic SP-B (surfactant protein B) and
SP-C are essential to promote transfer of surface-active complexes
to the interface, and to modulate the physical properties of the sur-
factant film under the dynamic conditions imposed by the res-
piratory cycle [3,4]. The precise role of SP-C in respiratory
physiology has still to be defined. This protein is not strictly
required to initiate respiratory function at birth, as seen from
animals in which expression of the SP-C gene has been genetically
deactivated [5,6]. However, surfactant obtained from the lungs of
these SP-C-knockout animals seem to be intrinsically unstable at
low lung volumes. Consistent with this fact, genetic deficiencies
in the structure and expression of the SP-C gene have been
found in patients developing chronic respiratory diseases [7,8].
Abbreviations used: ANTS, 8-aminonaphthalene-1,3,6-trisulphonic acid; Br(6,7)-PC, 1-palmitoyl-2-stearoyl(6-7)dibromo-sn-glycerol-3-phosphocholine;
Br(11,12)-PC, 1-palmitoyl-2-stearoyl(11-12)dibromo-sn-glycerol-3-phosphocholine; DPPC, 1,2-dipalmitoylphosphatidylcholine; DPPG, 1,2-dipalmitoyl-
phosphatidylglycerol; DPX, N,N′-p-xylene-bis-pyrimidinium bromide; PC, 1,2-diacylphosphatidylcholine; PG, 1,2-diacylphosphatidylglycerol; SP-B,
surfactant protein B; SP-C, surfactant protein C; LPS, lipopolysaccharide; 5-PCSL, 1-acyl-2-[5-(4,4-dimethyloxazolidine-N-oxyl)stearoyl]-sn-glycero-3-
phosphocholine; 5-PGSL, 1-acyl-2-[5-(4,4-dimethyloxazolidine-N-oxyl)stearoyl]-phosphatidylglycerol.
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SP-C is a 35-amino acid lipopeptide with a molecular mass
of 4 kDa [9]. Its structure has been determined in chloroform/
methanol solutions [10]. The protein consists of a regular hydro-
phobic α-helix comprising 23 residues, and a more polar 10-
residue N-terminal segment that contains stoichiometrically
palmitoylated cysteines which has no defined conformation in
organic solvents or in detergent micelles [10,11]. The C-terminal
segment adopts a transmembrane orientation in phospholipid
bilayers [12,13] but the disposition of the N-terminal segment
in membranes is unknown. Numerous studies have characterized
lipid–protein interactions and lipid-perturbing effects of SP-C,
in an attempt to understand the ability of SP-C to modulate
the surface-active properties of surfactant in molecular terms
[13–21]. A major problem is that most of the physico-chemical
features of SP-C are dominated by contributions from the hydro-
phobic α-helix, making it difficult to assign relevant properties
originating from the N-terminal segment of the protein. Lipid–
protein interactions involving this region of SP-C have been
studied previously by using protein forms that were chemically
derivatized to introduce extrinsic probes at the N-terminal end
[22,23]. Those studies indicated that the N-terminal segment of
SP-C is located at the surface of phospholipid bilayers, exposed
to the aqueous environment. The presence of anionic lipid species
is found to have important effects on the disposition of the
N-terminal segment of SP-C in membranes. The main objective of
the present work was to test whether the primary sequence of the
N-terminal segment of SP-C has intrinsic determinants to cause
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it to associate with and perturb membranes, independently of its
acylation state. We propose that the intrinsic properties of this
region in the native protein, especially its ability to interact with
and perturb phospholipid surfaces, are relevant to understanding
the role of SP-C in pulmonary surfactant function.
EXPERIMENTAL
Materials
Chloroform and methanol were HPLC-grade solvents from
Scharlau (Barcelona, Spain). The lipids DPPC, DPPG (1,2-dipal-
mitoylphosphatidylglycerol), egg yolk PC (1,2-diacylphos-
phatidylcholine) and egg yolk PG (produced by transphosphati-
dylation of egg yolk PC), Br(6,7)-PC [1-palmitoyl-2-stearoyl
(6-7)dibromo-sn-glycerol-3-phosphocholine] and Br(11,12)-PC
[1-palmitoyl-2-stearoyl(11-12)dibromo-sn-glycerol-3-phospho-
choline] were purchased from Avanti Polar Lipids (Birmingham,
AL, U.S.A.). Radiolabelled 1,2-di-[1-14C]palmitoyl-PC (112
Ci/mol) was from Amersham International (Little Chalfont,
Bucks., U.K.). Spin-labelled phosphatidylcholines, with the
nitroxide group at different positions of the sn-2 acyl chain, were
synthesized as described by Marsh and Watts [24]. The spin
labels were stored at − 20 ◦C in chloroform/methanol (2/1, v/v)
solutions at a concentration of 1 mg/ml.
Peptide synthesis and purification
Two 13-residue peptides were synthesized by Fmoc (fluoren-
9-ylmethoxycarbonyl) chemistry, as described elsewhere [25],
taking the sequence of porcine SP-C as a template. The N-terminal
leucine residue in the native sequence was replaced in the two
synthetic peptides by tryptophan, with the aim of using this as an
intrinsic probe to characterize lipid–protein interactions by fluo-
rescence spectroscopy. A peptide, named pSP-CL1W (NH2-WRI-
PCCPVNLKRL-CONH2), has the two cysteines of the native
sequence bearing free thiol groups, while the peptide pSP-CL1Wb
(NH2-WRIPOOPVNLKRL-CONH2) is a variant with the two
thiols blocked by acetamidomethyl groups (O). Purity of the
products of synthesis was checked by MALDI-TOF (matrix-
assisted laser desorption-ionization time-of-flight) MS analysis
and N-terminal Edman amino acid sequencing.
Lipid/peptide samples
Phospholipid vesicles for the binding experiments were prepared
by extrusion of the appropriate lipid suspensions, equilibrated
at temperatures above the chain-melting temperature of the cor-
responding lipid, through 0.1 µm (pore diameter) polycarbonate
membranes (Nucleopore; Costar, Cambridge, MA, U.S.A.) in an
Extruder (Lipex, Biomembranes, Vancouver, Canada). The lipid
suspensions contained a trace of radioactive phospholipid (1,2-
di-[14C]palmitoyl-PC, 55 mCi/mol) to facilitate rapid lipid quan-
titation. The extruded vesicles (phospholipid concentration,
0.43 mM) were incubated overnight at 37 ◦C, with or without pep-
tide injected from a concentrated methanolic solution (17 µg/ml
final concentration, 1:44 peptide/lipid molar ratio).
In the fluorescence spectroscopy experiments, small aliquots,
typically 5–10 µl, of concentrated 1 mg/ml methanolic solutions
of the peptides were injected into suspensions of lipid vesicles
prepared by extrusion as described above in 50 mM Hepes buffer
containing 150 mM NaCl, pH 7.0. To analyse quenching of pep-
tide tryptophan fluorescence by brominated lipids, PC vesicles
were prepared containing different weight percentages of Br(6,7)-
PC or Br(11,12)-PC, with or without peptide, at a peptide/lipid ratio
of 1:45 (mol/mol).
To carry out differential scanning calorimetry experiments,
DPPC and the desired amount of peptide (stored in methanol
solution) were pre-mixed in chloroform/methanol (2:1, v/v), dried
under a N2 stream, and reconstituted as multilamellar suspensions.
To achieve this, lipid or peptide/lipid samples were hydrated in
1 ml of buffer (50 mM Hepes/150 mM NaCl, pH 7) at 50 ◦C for
1 h, with occasional vortex mixing.
For ESR experiments, appropriate amounts of DPPC or DPPG
and the selected spin-labelled lipid (1 mol%) were dissolved in
chloroform/methanol (2:1, v/v), and mixed with the desired
amount of peptide. Multilamellar suspensions were prepared in
100 µl of buffer (50 mM Hepes/150 mM NaCl, pH 7), and the
reconstituted material was pelleted in 100 µl capillary tubes for
ESR spectroscopy by centrifugation at 1500 g in a bench-top
centrifuge.
Lipid/peptide-binding experiments
Free and vesicle-bound peptide fractions were separated by centri-
fugation of the peptide–lipid mixtures, after incubation under the
conditions described above, in a Beckman Airfuge (rotor A95)
for 1 h at 130 000 g at 4 ◦C. After centrifugation, 80 µl fractions
were taken from top to bottom of each tube and the tryptophan
fluorescence emission spectrum was recorded from each fraction
as explained below. Peptide concentration was determined
by amino acid analysis, and the phospholipid concentration by
quantification of radioactivity.
Fluorescence spectroscopy
Tryptophan fluorescence emission spectra of peptides were ob-
tained, using 280 nm as the excitation wavelength, either in a
Perkin-Elmer MPF-44E or in a SLM-Aminco AB-2 spectrofluori-
meter, operated in the ratio mode [26]. The spectra were recorded
at 25 ◦C at a scan rate of 1 nm/s, in cells under thermostat-con-
trolled conditions with a 0.2 cm optical path. The slit widths were
5 nm for both excitation and emission. All spectra were corrected
for scattering and inner filter effect as described previously [26].
Phospholipid vesicle aggregation assay
Peptide-induced phospholipid vesicle aggregation assays were
performed at 25 or 45 ◦C in a Beckman DU-640 spectrophoto-
meter, by monitoring changes in apparent absorbance at 400 nm
caused by increase in light scattering. Phospholipid vesicles were
added to both the sample and the reference cuvettes, in a total
volume of 300 µl of buffer (50 mM Hepes, pH 7, containing
150 mM NaCl). After 10 min of equilibration, different amounts
of peptide were added to the sample cuvette from a concentrated
methanolic solution, and the changes in absorbance at 400 nm
were monitored at 1 min intervals over 30 min. As a control, an
identical amount of methanol was added to a sample of vesicles
alone.
Leakage of vesicle aqueous contents
Peptide-induced release of aqueous vesicle content was measured
by using the ANTS (8-aminonaphthalene-1,3,6-trisulphonic
acid)/DPX (N,N ′-p-xylene-bis-pyrimidinium bromide) assay
[27]. DPPC or PG vesicles were prepared by extrusion of lipid
suspensions prepared in 50 mM Hepes buffer, pH 7, containing
30 mM NaCl, 12.5 mM of the fluorophore ANTS and 45 mM
DPX as a quencher. Vesicles were separated from unencapsulated
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material on a Sephadex G-75 column (Amersham Biosciences,
Uppsala, Sweden) by using 50 mM Hepes, pH 7, containing
150 mM NaCl, as elution buffer. We were not successful in pre-
paring stable DPPG vesicles that encapsulated significant amounts
of fluorophore. In a typical assay, a given volume of peptide was
added from a concentrated methanolic solution to the ANTS/
DPX-loaded vesicles at 75 µM lipid. The resulting leakage was
then followed by measuring the increase in fluorescence emission
intensity at 536 nm, upon excitation at 386 nm, in a SLM-Aminco
AB-2 spectrofluorimeter. The 0 and 100% limits of leakage were
taken as the fluorescence intensity of the DPPC or PG vesicle
suspension before and after, respectively, addition of an aliquot of
Triton X-100 to yield a final detergent concentration of 0.5%
(w/v).
Differential scanning calorimetry
Multilamellar suspensions of DPPC (1 mg/ml, final concentra-
tion), in the absence or in the presence of different amounts of
peptide, were loaded in the sample cell of a MicroCal MC-2
microcalorimeter, with buffer in the reference cell. Three calori-
metric scans between 25 and 60 ◦C were collected from each
sample, at a rate of 0.5 ◦C/min.
ESR spectroscopy
ESR spectra of lipid and lipid/peptide samples were recorded on
a Varian E-12 Century Line 9 GHz spectrometer equipped with a
nitrogen gas flow temperature-regulation system. The sealed ca-
pillaries (1 mm outer diameter) were placed in a quartz tube con-
taining light silicone oil for thermal stability. Temperature was
measured with a fine-wire thermocouple positioned in the silicone
oil at the top of the microwave cavity. Spectra were collected
digitally on a personal computer with Labmaster interface. Instru-
mental settings were as follows: 10 mW microwave power, 1.25 G
modulation amplitude, 100 kHz modulation frequency, 0.25 s
time constant, 4 min scan time, 100 G scan range and 3245 G
centre field. Several scans, typically three to five, were accumu-
lated to improve the signal-to-noise ratio. See Perez-Gil et al. [18]
for details of spectral analysis.
RESULTS
Lipid/peptide binding
Figure 1 illustrates the ability of peptides pSP-CL1W and pSP-
CL1Wb to distribute between water and the lipid phase in a sus-
pension of PC or PG vesicles. In the absence of lipids, the two
peptides were soluble in the buffer and no peptide accumulation
was detected at the bottom of the tube after extensive centrifu-
gation. When PC or PG vesicle suspensions were centrifuged,
more than 90% of the lipid was collected in the pellet. If lipid
vesicle suspensions were incubated with either pSP-CL1W or pSP-
CL1Wb peptide, the lipids were again completely pelleted upon
centrifugation, but now substantial portions of both peptides were
co-pelleted with the vesicles. PC membranes bound around 70%
of either peptide, while PG vesicles bound more than 90% of
pSP-CL1Wb or pSP-CL1W. Determination of the proportion of either
peptide bound to the membranes allows estimation of their
apparent mole fraction surface partition coefficients K [28],
according to the equation:
f bound = KL/(W + KL) (1)
where f bound is the molar fraction of peptide bound to the mem-
branes, K is the mole-fraction partition coefficient, L is the concen-
tration of accessible lipid (60% of the total lipid concentration,
representing the outer leaflet of the membrane bilayers) and W is
the molar concentration of water (55.3 M at 25 ◦C). The blocked
peptide pSP-CL1Wb had a partition coefficient K of ≈4.6 × 105
in PC and ≈1.8 × 106 in PG. The peptide with free cysteines,
pSP-CL1W, had coefficients in the same range, K ≈ 4.3 × 105 and
≈2.0 × 106 in PC and PG, respectively. Although the intrinsic
partition coefficients in anionic membranes may be somewhat
overestimated due to electrostatic effects that increase the aqueous
concentration of peptides at the membrane surface, these results
indicate that the peptides have a marked intrinsic affinity for
association with lipid membranes. Both peptides have a higher
apparent affinity for anionic, as opposed to zwitterionic, bilayers.
The calculated partition coefficients represent a free energy of
transfer of both peptides from the aqueous to the lipid phase which
is around − 7.7 and − 8.5 kcal/mol for PC and PG membranes,
respectively. These values are of a similar order to those found
for other membrane-interacting peptides [29,30].
Figure 1 also shows the fluorescence emission spectra of the
peptides in the different fractions, obtained in the presence or
absence of phospholipids. In the absence of lipids, both peptides
have fluorescence spectra with emission maxima at 345–350 nm,
typical of tryptophan residues exposed to polar microenviron-
ments. In contrast, the spectra of peptides associated with lipids
have maxima shifted to ≈330 nm, indicating that association of
the peptide with membranes places the tryptophans in a much
more hydrophobic environment. The present results indicate that
the two peptides show quite comparable behaviour in terms of
lipid–protein binding, indicating that thiol blockage by itself does
not significantly modify the intrinsic propensity of the sequence to
interact with membranes. Although most of the data that follow
refer to the properties of the blocked peptide, the free-cysteine
version always exhibited qualitatively comparable features.
Lipid–peptide titration
We next analysed the effect of PC or PG lipid/peptide ratio on the
fluorescence properties of the peptides. Figure 2 shows the emis-
sion fluorescence spectra of pSP-CL1Wb in the absence and in the
presence of increasing quantities of PC or PG vesicles.
Both PC and PG membranes produce a progressive increase
in peptide fluorescence intensity that was shifted to progressively
shorter wavelengths as the lipid concentration increased. The in-
crease in fluorescence emission intensity and the shift of the
emission maximum to shorter wavelengths were both markedly
larger when the peptide interacted with anionic as opposed to
zwitterionic membranes.
Tryptophan quenching by brominated lipids
Figure 3 shows fluorescence emission spectra of pSP-CL1Wb in PC
vesicles containing different weight percentages of brominated
PC bearing bromines either at the (6,7) or at the (11,12) positions
of its acyl chains. Increasing amounts of both brominated lipid
probes produce progressive quenching of peptide fluorescence as
a result of association of the peptide with the membranes.
Quantitative comparison of quenching by the two brominated
lipids allows estimation of the relative position of the peptide
tryptophan in the bilayers, provided that the location in the mem-
brane of the two quenching groups is known. This ‘parallax’
method has been used previously by our group to estimate the
insertion depth of surfactant protein SP-B in lipid bilayers [26].
Figure 3(B) shows that the extent of quenching of peptide fluor-
escence by the Br(6,7) isomer is clearly higher than that of
c© 2004 Biochemical Society
186 I. Plasencia and others
Figure 1 Association of peptides pSP-CL1W and pSP-CL1Wb with egg PC or egg PG vesicles in 50 mM Hepes/150 mM NaCl, pH 7
Lipid/peptide molar ratio was 44. The bar charts show the percentage of peptide and the percentage of lipid in each of five ultracentrifuge fractions, separated as indicated by the scheme in the
upper right-hand corner. Quantification of the lipid and peptide contents in each fraction was performed as described in the Experimental section. Tryptophan emission fluorescence spectra are also
included from the different fractions, 1–5. Spectra were obtained at 25 ◦C, with an excitation wavelength of 280 nm. Fluorescence emission is presented in arbitrary units (a.u.). F.I., fluorescence
intensity.
quenching by the Br(11,12) isomer. Applying the parallax analysis
to these data, it was possible to estimate that the peptide tryptophan
is located in a region 11 +− 1 Å from the bilayer centre. This value
suggests an interfacial disposition in the bilayer for the N-terminal
tryptophan of the peptide.
Phospholipid vesicle aggregation
Addition of peptide pSP-CL1Wb to preformed DPPC or DPPG
vesicles promotes an almost instantaneous increase in light scat-
tering, at peptide/lipid molar ratios ranging from 1:110 to 1:12
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Figure 2 Titration of peptide pSP-CL1Wb–lipid interaction by fluorescence spectroscopy
(A, D) Fluorescence emission spectra of peptide pSP-CL1Wb (4 µg/ml) in the absence (spectrum 1) or presence of 5, 11, 21, 27, 53, 80 or 107 mM (spectra 2–8) egg PC (A) or egg PG
(D) vesicles, in 50 mM Hepes buffer, pH 7, containing 150 mM NaCl. The excitation wavelength was 280 nm and the temperature was 25 ◦C. (B, E) Maximal fluorescence emission intensity and
(C, F) wavelength of maximum emission, all plotted versus lipid to peptide molar ratio. Lines in (B), (C), (E) and (F) are visual guides to show the trend in the experimental data.
Figure 3 Quenching of the fluorescence of peptide pSP-CL1Wb by brominated phospholipids
(A) Fluorescence emission spectra at 25 ◦C of peptide pSP-CL1Wb in PC bilayers containing 0 (), 10 (), 20 (), 30 (), 40 (H17009) and 50 % (; w/w) of Br(6,7)-PC (left-hand panel) or Br(11,12)-PC
(right-hand panel). The excitation wavelength was 280 nm and the fluorescence intensity is given in arbitrary units. (B) Semilogarithmic plot of the relative fluorescence intensity of the emission
spectra of peptide pSP-CL1Wb in PC membranes as a function of the molar fraction of Br-PC in the bilayers.
(Figure 4). This suggests that the peptide causes rapid vesicle ag-
gregation. For any given temperature, the extent of aggregation
induced, measured as the increment in absorbance, is greater with
anionic vesicles than with DPPC vesicles.
Peptide pSP-CL1Wb induces little aggregation of zwitterionic
vesicles at temperatures above their gel-to-liquid crystalline trans-
ition temperature (Tm). However, the peptide promotes aggre-
gation of DPPG vesicles at both 25 and 45 ◦C; temperatures below
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Figure 4 Aggregation of phospholipid vesicles induced by peptide pSP-CL1Wb
(A) Aggregation of DPPC (upper panels) or DPPG (lower panels) vesicles induced by the peptide pSP-CL1Wb. Phospholipid vesicles were prepared at 100 µg/ml in 50 mM Hepes/150 mM NaCl,
pH 7, buffer which was equilibrated at 25 ◦C (left) or 45 ◦C (right). At the time indicated by the arrow, an aliquot of 10 µl of methanol () or a concentrated methanolic solution of the peptide was
injected to produce final peptide concentrations of 2 (), 5 (), 10 () and 20 () µg/ml, corresponding to lipid/peptide molar ratios of 110, 48, 24 and 12, respectively. Vesicle aggregation
induced by the peptide was followed by monitoring the turbidity detected at 400 nm. (B) Percentage of vesicle aggregation induced at 45 ◦C by the peptide pSP-CL1Wb versus the molar fraction of
DPPG in DPPC bilayers, taking aggregation of pure DPPG vesicles as a reference.
and above the Tm of DPPG with sodium as the counterion. Fig-
ure 4 also illustrates how the inclusion of a small proportion of PG
in zwitterionic membranes is sufficient to make them susceptible
to aggregation by the SP-C N-terminal peptide. The presence of as
little as 2% DPPG in DPPC bilayers, which are not aggregated
by the peptide at temperatures above Tm, confers sensitivity to
peptide-induced aggregation. Remarkably, sensitivity to aggrega-
tion seems to be maximal already in the presence of 8% PG, i.e.
on the order of the physiological content of anionic phospholipid
species in surfactant.
Leakage of aqueous content
Perturbation of phospholipid bilayers induced by these peptides
also affects membrane permeability. Both pSP-CL1W and pSP-
CL1Wb induce leakage of the aqueous content from both zwitter-
ionic and anionic vesicles, above their respective Tm values
(Figure 5). Peptide-induced leakage of vesicle contents was al-
ways associated with a marked increase in light scattering,
implying that leakage is not likely due to a general solubilizing
‘detergent-like’ effect of the peptide. The time required for the
peptide to produce maximum leakage, as well as the maximal
amount of fluorescence liberated, were both dependent on peptide
concentration.
Differential scanning calorimetry
The effect of pSP-CL1Wb on the thermotropic properties of DPPC
bilayers is shown in Figure 6. Increasing amounts of peptide in
the bilayers abolish the Lβ-Pβ′ transition, which in DPPC occurs
at 36.5 ◦C, and produce progressive broadening and reduction
of the amplitude of the major calorimetric peak associated with
the chain-melting transition, without significant shift in the Tm at
which this transition occurs (around 41 ◦C).
Table 1 summarizes the values of the thermodynamic para-
meters determining the principal thermotropic transition in DPPC
bilayers associated with different proportions of peptide. These
are derived from the thermograms in Figure 6. The peptide pSP-
CL1Wb produces significant effects on both the co-operativity of
the transition, characterized by the width T1/2, and the associated
enthalpy change (H). These effects suggest the existence of a
marked hydrophobic component for the peptide–lipid interaction,
the peptide inducing significant perturbations in phospholipid acyl
chain packing.
ESR spectroscopy
The effect of pSP-CL1Wb on the gel to liquid-crystalline phase
transition of DPPC and DPPG bilayers, as studied by ESR, is
illustrated in Figure 7. The outer hyperfine splitting (2Amax) of
the ESR spectra of DPPC or DPPG bilayers containing, res-
pectively, 1 mol% of a 5-position spin-labelled PC {5-PCSL; 1-
acyl-2-[5-(4,4-dimethyloxazolidine-N-oxyl)stearoyl]-sn-glycero-
3-phosphocholine} or PG {5-PGSL, 1-acyl-2-[5-(4,4-dimethyl-
oxazolidine-N-oxyl)stearoyl]-phosphatidylglycerol}, is plotted
against temperature, for both the pure lipid and the lipid–
peptide systems containing 40% (w/w) pSP-CL1Wb. The depen-
dence of 2Amax on the amount of peptide pSP-CL1Wb in the
bilayers was monotonic over a wide range of lipid/protein ratios,
up to >40% peptide/lipid by weight, which corresponds to a
1:5.6 peptide/lipid molar ratio (results not shown). Lipid/peptide
samples containing 40% (w/w) pSP-CL1Wb were then chosen for
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Figure 5 Effect of peptides pSP-CL1Wb (left-hand panels) and pSP-CL1W (right-hand panels) on the release of aqueous contents from DPPC or PG vesicles
Peptide concentrations assayed were (from light grey to black) 1, 3, 6 and 12 µM, corresponding to lipid/peptide molar ratios of 75, 25, 12.5 and 6.25, respectively, and the final lipid concentration
was 75 mM. Peptide-induced liberation of the fluorophore ANTS from the vesicles was followed by monitoring fluorescence emission using excitation and emission wavelengths of 353 and 536 nm,
respectively. The percentage of leakage induced by any given peptide concentration was estimated taking as a reference the maximum possible leakage, obtained after addition to the samples of an
aliquot of Triton X-100 (final concentration 0.5 %, v/v). Measurements were made at 45 ◦C for the samples containing DPPC vesicles and at 25 ◦C for the samples containing PG vesicles.
most ESR experiments, because at this peptide/lipid ratio the
effect of interaction is practically saturated. Dispersions of both
DPPC and DPPG alone showed sharp phase transitions at around
40–41 ◦C, as seen from Figure 7. In DPPC bilayers, the pre-
sence of pSP-CL1Wb caused a remarkable broadening of the main
transition without shifting the temperature of the transition mid-
point appreciably. In contrast, the peptide caused a 2 ◦C shift in
Tm of DPPG membranes to lower temperatures. Also, the peptide
decreased the amplitude of the change in 2Amax at the transition,
for both DPPC and DPPG bilayers.
The peptide has different effects on the lipid mobility in the gel
and the fluid phases of DPPC and DPPG bilayers. In DPPC mem-
branes, pSP-CL1Wb increases the outer splittings of the ESR spec-
tra in the lipid fluid phase, apparently without modifying the ESR
spectral characteristics of the spin-labelled lipids at temperatures
in the gel phase. On the other hand, DPPG–peptide interaction
increases 2Amax of 5-PGSL in both gel and liquid-crystalline
phases.
Figure 7 also plots the outer hyperfine splitting of different
PC (n-PCSL) or PG (n-PGSL) spin-label positional isomers ver-
sus the position of the spin label group in the sn-2 acyl chain of
the phospholipid, in the absence and presence of 40% (w/w)
pSP-CL1Wb at 45 ◦C. At this temperature, both DPPC and DPPG
are in the fluid phase, where the peptide has the strongest
immobilization effects. The bilayers of both phospholipids display
the characteristic chain flexibility gradient, both in the absence and
in the presence of the peptide. The motional restriction induced
by the peptide is always larger at chain positions close to the polar
headgroups, where presumably the peptide interacts. At most of
the acyl chain segments, the peptide also produces larger im-
mobilizations in DPPG than in DPPC bilayers, as a result of the
additional electrostatic component of the peptide/membrane inter-
action in the former case.
DISCUSSION
Most models that address the structure and disposition of pul-
monary surfactant lipopeptide SP-C in phospholipid bilayers
and monolayers propose that the N-terminal segment of the pro-
tein, which accounts for approximately one-third of its sequence,
is strongly associated with the lipids via its palmitoylated cys-
teines [31]. The other approximately two-thirds of the structure in
SP-C consists of a highly hydrophobic α-helix, with a transmem-
brane orientation in bilayers [13], and which is possibly being
directed towards the air spaces when at the air–liquid interface
[32]. The results of the present study indicate that the sequence
comprised of the 13 N-terminal residues of SP-C has an intrinsic
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Figure 6 Differential scanning calorimetry
Shown are differential scanning calorimetry thermograms of DPPC multilamellar suspensions
reconstituted in the absence or presence of 4, 10, 20 and 40 % by weight of pSP-CL1Wb relative
to lipid (lipid/peptide molar ratios of 56, 22.4, 11.2 and 5.6, respectively). Three comparable
heating cycles from 20 to 60 ◦C were scanned for each sample at 30 ◦C/h.
ability to interact and associate spontaneously with lipid mem-
branes, even in the absence of thioester-linked palmitic chains.
We have previously proposed that the conformation of the
N-terminal segment of SP-C could be defined by a high intrinsic
propensity to form β-turns [25]. From the sequence of this seg-
ment of the protein, the middle part of the turn would be oc-
cupied by hydrophobic residues while both ends would contain
polar, positively charged amino acids. It is conceivable that such
an amphipathic β-hairpin would have intrinsic tendency to as-
sociate with the polar/non-polar interface offered by the mem-
brane surface. The β-turn conformation could require partial
charge compensation in order to facilitate approach of the two cat-
ionic ends of the N-terminal segment (see Figure 8). Negatively
charged lipids, such as surfactant PG, could therefore be required
to supply appropriate counterions to stabilize the β-hairpin motif.
NMR experiments on a 17-residue peptide from the N-terminal
Table 1 Thermodynamic parameters characterizing the effect of peptide
pSP-CL1Wb on the main phase transition of multilamellar DPPC suspensions,
as determined by DSC
H is the enthalpy of the chain-melting transition, T m is the temperature of the transition
mid-point and T 1/2 is the width of the transition.
H (kcal/mol) T m (◦C) T 1/2 (◦C)
DPPC 8.2 41.8 0.5
DPPC/4 % pSP-CL1Wb 10.2 42.0 0.5
DPPC/10 % pSP-CL1Wb 9.0 42.0 0.5
DPPC/20 % pSP-CL1Wb 6.7 42.0 0.8
DPPC/40 % pSP-CL1Wb 5.3 41.8 1.5
Figure 7 Effect of peptide pSP-CL1Wb on the thermotropic properties and
the flexibility profile of DPPC or DPPG bilayers
(A) Effect of temperature on the outer hyperfine splitting constant, 2A max, in the ESR spectra
of DPPC (upper panel) or DPPG (lower panel) bilayers containing 1 mol % of the spin probes
5-PCSL or 5-PGSL, respectively, in the absence () and presence () of 40 % by weight
of pSP-CL1Wb relative to lipid. (B) Dependence of 2A max on the nitroxide position in sn-2
positional spin-labelled PC isomers in DPPC bilayers (above) or sn-2 positional PG isomers
in DPPG bilayers (below) at 45 ◦C, in the absence () and presence () of 40 % by weight of
pSP-CL1Wb.
sequence of SP-C in zwitterionic dodecylphosphocholine micelles
did not detect any defined conformation [11]. Apart from a pos-
sible unfavourable geometry of micelles compared with bilayers,
we suggest that formation of the β-hairpin motif could be impaired
in the absence of anionic lipid species.
Figure 8 represents theoretical membrane-partitioning tenden-
cies in the primary sequence of proSP-C and mature SP-C from
several species, according to the scales proposed by Wimley and
White [33]. In this figure, the average interfacial hydrophobicity
of the different sequence segments are plotted versus residue
position. In the same plots, profiles of free energy of transfer from
water to octanol and Kyte–Dolittle hydrophobicity are also super-
imposed. These latter two indices identify highly hydrophobic
segments that could potentially partition into the core of lipid
bilayers. Two segments in the sequence of SP-C have a free energy
that is predicted to be favorable for partitioning into and asso-
ciation with membranes. The C-terminal α-helical segment,
including residues 13–35 of the mature sequence, has a high ab-
solute hydrophobicity, as one would expect for the hydrophobic
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Figure 8 Model for the disposition of SP-C N-terminal region in phospholipid bilayers
(A) Schematic illustration of the disposition of SP-C and its N-terminal segment in phospholipid bilayers. Polar and non-polar segments in the sequence have been marked as dark and light portions,
respectively. Bold lines indicate the surfaces of the bilayers. Negatively charged phospholipids are represented as stabilizers of the amphipathic β-hairpin. (B) Hydropathy profiles of proSP-C or
mature SP-C sequences from different species. Bold lines are plots calculated using the White–Wimley interfacial hydrophobicity scale [33] based on the free energy of transfer from water to the
membrane interface (mean values for a window of six residues). Dashed lines are plots using an scale based on the free energy of transfer from water to octanol. Continuous thin lines are plots using
the traditional hydrophobicity index proposed by Kyte and Doolittle [50]. The two segments in the sequence of mature SP-C with highest hydrophobicity are positioned in the ribbon diagram of the
protein.
transmembrane region of the protein. The second region in SP-C
that has a favourable free energy for interacting with membranes
extends from residue 2 or 3 to 8 of the mature sequence and would
form the middle part of the N-terminal β-hairpin proposed above.
Our results suggest that the affinity and extent of the interaction
of the N-terminal segment of SP-C are considerably greater for
anionic than for zwitterionic membranes. Also, the N-terminal
segment resides deeper in the interfacial regions of anionic as
opposed to zwitterionic membranes (seen, for instance, by a much
larger blue-shift of tryptophan fluorescence emission in Figure 2).
The importance of an electrostatic component for the lipid–protein
interaction of SP-C has been reported previously [15,18,34].
Native SP-C [21], and specifically its N-terminal segment [23],
adopts a location and conformation in anionic phospholipids dif-
ferent from that in zwitterionic phospholipids. Positively charged
residues in SP-C seem to be essential for the biophysical activity
of the protein [17], supporting the idea that the interaction between
its N-terminal segment and anionic phospholipid head-groups has
a functional significance. Pulmonary surfactant contains about
8% of anionic phospholipids [35], mostly PG and phosphatidyl-
inositol. We propose that these lipids provide sufficient negative
charge at surfactant bilayer surfaces to ensure the proper confor-
mation/disposition of the SP-C N-terminal segment, an effect
potentially mimicked by the synthetic peptides used in this study.
We propose also that embedding of the N-terminal segment of
SP-C in the bilayer surface is probably an important feature in
modulating lateral distribution of the protein in surfactant mem-
branes [23].
It has been shown recently that SP-C has the capacity to bind
bacterial endotoxin [LPS (lipopolysaccharide)] inserted in mem-
branes [36]. Structural features of the N-terminal segment of SP-C
are essential for LPS binding [37]. We suggest that the structure
and amphipathicity of the N-terminal segment of SP-C could
direct formation of specific SP-C–LPS complexes. The impor-
tance of this LPS-binding activity for the anti-bacterial defence
mechanisms of the lungs has still to be established.
The results presented in this study further indicate that the
N-terminal segment of SP-C not only interacts with lipid mem-
branes but also induces perturbations of the lipid packing that
extend more or less deeply into the bilayer. These perturbations
cause peptides from this region of SP-C to induce lipid vesicle
aggregation and leakage of their aqueous contents. At tempera-
tures below Tm, the peptides are probably excluded from the
ordered lipid phases and do not cause substantial effects on
the packing of the phospholipid acyl chains. Peptide-induced
aggregation of phospholipid vesicles at those temperatures could
be induced by insertion of the peptide into dislocations at
the gel-fluid boundaries, but also by electrostatic lipid–protein
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interactions at the surface of anionic membranes. Above Tm, in the
absence of such dislocations, the peptide only aggregates anionic
membranes, probably requiring an electrostatic component,
which is independent of the physical state of the membranes
themselves. Lipid–peptide interactions producing leakage at tem-
peratures above Tm may require a different location or disposition
of the peptide in the membranes than that at temperatures below
Tm. A preliminary analysis of the kinetics of peptide-induced
leakage and its dependence on lipid/peptide ratio [38] seems
to indicate that leakage could proceed via formation of ‘pore-
like’ structures. Formation of peptide transmembrane pores would
necessarily imply peptide oligomerization occurring at the surface
of the membranes, followed by insertion of the peptide assemblies
in a transmembrane orientation. A similar behaviour has been
proposed for other amphipathic peptides that were able to
aggregate and form pores depending on the lipid membrane phase
[38]. Interestingly, membranes formed from pulmonary surfactant
extracts containing the hydrophobic proteins SP-B and SP-C, have
been reported to contain discrete pores or channels [39], raising
the question of a possible physiological significance for protein-
promoted channel-like structures in surfactant membranes.
The membrane-perturbing properties of the N-terminal segment
might well underly the ability of SP-C to induce mixing of lipid
components between vesicles [14], or to catalyse bilayer-to-
monolayer phospholipid transfer [40]. Both differential scanning
calorimetry and especially spin-label ESR experiments, allow us
to conclude that the SP-C N-terminal region has significant effects
on the order/mobility of segments of the phospholipid acyl chains
located deep in the hydrophobic core of the membranes. The
hydrophobic component of the peptide–lipid interaction is present
even in anionic membranes, where electrostatic interactions con-
tribute strongly. The dominant hydrophobic component of the SP-
C–phospholipid interaction has been widely studied [16,41,42],
always being attributed to lipid–protein interactions arising
mainly from the transmembrane hydrophobic α-helix, which ex-
tends over residues 13–35 of the mature protein. The present
results provide evidence that interaction of the N-terminal seg-
ment with membranes also affects the hydrophobic interior of the
membrane, even in the absence of cysteine thio-acylation. This
interaction might be essential for certain roles of SP-C in the
lung such as promoting the bilayer–monolayer transitions that
bring the surface-active lipid molecules to the alveolar air–liquid
interface [43]. Palmitoylation probably has a rather subtle role
in modulating conformation and lipid–protein interactions of the
N-terminal tail in native SP-C.
Several studies published in recent years have suggested that
the interfacial surface-active monolayer is associated in vivo with
bilayer-based structures near and below the surface. These bi-
layers could act as a reservoir to supply new surfactant molecules
to the interface during successive respiratory cycles [20,44]. The
lipopeptide SP-C has been proposed to participate in the establish-
ment and maintenance of such interfacial reservoirs, with the
N-terminal segment of the protein assuming a principal role
[45–47]. It has been shown recently that acylation of this region
could be essential to maintain association of the reservoirs with
compressed states of the interfacial film at the end of expiration
[46,48]. Upon inspiration, the perturbations introduced by the
N-terminal protein segment in surfactant bilayers and monolayers
could catalyse the formation of the intermediate structures
necessary to promote a rapid and continuous transfer of surfactant
molecules to the interface [49].
The N-terminal region of pulmonary surfactant protein SP-C
has an intrinsically dynamic behaviour in terms of lipid–protein
interactions and membrane perturbations. The physico-chemical
properties of this segment of the protein necessarily have to be
considered to understand the role of SP-C in surfactant biophysics
at the alveolar spaces, and when designing SP-C-based surfactant
preparations for respiratory therapies.
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